GW Pharmaceuticals PLC (GWPH)

81.63
NASDAQ : Health Care
Prev Close 81.54
Day Low/High 81.16 / 84.04
52 Wk Low/High 35.83 / 120.94
Avg Volume 506.30K
Exchange NASDAQ
Shares Outstanding 21.77M
Market Cap 1.77B
EPS -3.30
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

'Mad Money' Lightning Round: Weight Watchers Is Not for Me

'Mad Money' Lightning Round: Weight Watchers Is Not for Me

Cramer says sell Stryker and buy Zimmer Biomet, and take Randgold over Barrick Gold.

Jim Cramer's 'Mad Money' Recap: I Can't Figure Out the Consumer

Jim Cramer's 'Mad Money' Recap: I Can't Figure Out the Consumer

The economy needs consumers to buy, buy, buy but so far consumers have been all over the map, Cramer says.

Why Nasdaq-Traded Marijuana Stocks Remain Undervalued

Why Nasdaq-Traded Marijuana Stocks Remain Undervalued

Nasdaq-traded marijuana stocks are undervalued as investors remain skittish and the use of drugs produced by these biopharmaceutical companies have not been widely adopted.

Consumer Staples And Utilities Sectors Avoided Volatility in Brexit Aftermath

Consumer Staples And Utilities Sectors Avoided Volatility in Brexit Aftermath

Investors should stick with buying stocks in the utilities and consumer staples sectors, which rose higher in the aftermath of the Brexit vote and avoided the massive volatility.

Janney Says Sell GW Pharma Despite Marijuana-Derived Drug Success In Seizures

Janney Says Sell GW Pharma Despite Marijuana-Derived Drug Success In Seizures

Shares of GW Pharmaceuticals are on the rise after the company announced this morning positive Phase 3 results for its Epidiolex for the treatment of Lennox-Gastaut syndrome, or LGS.

GW Pharmaceuticals (GWPH) Moving On Heavy Volume In The Pre-Market Hours

GW Pharmaceuticals (GWPH) Moving On Heavy Volume In The Pre-Market Hours

Trade-Ideas LLC identified GW Pharmaceuticals (GWPH) as a pre-market mover with heavy volume candidate

GW Pharma Marijuana Drug Confirms Seizure Benefit in Second Pivotal Trial

GW Pharma Marijuana Drug Confirms Seizure Benefit in Second Pivotal Trial

GW Pharmaceuticals announced positive results Monday from a second, pivotal clinical trial involving children with a severe form of epilepsy treated with its experimental marijuana-based drug.

Brexit Vote Leaves Investors Cautious

Folks are anxious, dying to be bullish yet also curbing their enthusiasm.

Here’s How You Should Invest If Gary Johnson Makes It to the White House

Here’s How You Should Invest If Gary Johnson Makes It to the White House

It may not be the likeliest of scenarios, but if Gary Johnson becomes president of the United States, investors might want to shift some money around. Here's how.

Jim Cramer's 'Mad Money' Recap: Here's This Week's Game Plan

Jim Cramer's 'Mad Money' Recap: Here's This Week's Game Plan

'Brexit' will be Cramer's focus, along with company earnings and Fed Chair Janet Yellen's congressional testimony.

'Mad Money' Lightning Round: Buy, Buy, Buy Edward Lifesciences

'Mad Money' Lightning Round: Buy, Buy, Buy Edward Lifesciences

Cramer says American Tower is a buy and is hesitant on B&G Foods.

Economics of Pot: The Problems With Investing in Marijuana

Economics of Pot: The Problems With Investing in Marijuana

As more states consider legalizing the drug for recreational use, forward-thinking investors are wondering how to profit.

'Mad Money' Lightning Round: Buy, Buy, Buy Intuit

'Mad Money' Lightning Round: Buy, Buy, Buy Intuit

Cramer says Time Warner is a good stock but you should sell Interoil.

Jim Cramer's 'Mad Money' Recap: Stay Disciplined in This Market

Jim Cramer's 'Mad Money' Recap: Stay Disciplined in This Market

How does Cramer know that investors are getting careless? Because they see takeovers everywhere.

4 Top Stocks in the Growing Medical Marijuana Industry

4 Top Stocks in the Growing Medical Marijuana Industry

Weed has gone from a taboo substance to a multi-billion-dollar bonanza. The growth of the marijuana sector has created opportunities for investors. Here are four to watch.

5 Stocks Set to Soar on Bullish Earnings

5 Stocks Set to Soar on Bullish Earnings

These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.

Making the Right Budding Investment: Medical Versus Recreational Cannabis Companies

Making the Right Budding Investment: Medical Versus Recreational Cannabis Companies

Investors choosing among the hundreds of cannabis businesses are often caught in a conundrum as to whether medical companies are a safer investment compared to recreational businesses.